Abstract
A new generation of cycloSal-pronucleotides is presented. CycloSal-d4TMPs have been modified by introduction of an esterase-cleavable site in order to trap them inside cells. Hydrolysis studies in different media (PBS, CEM/0- and liver extracts) and anti-HIV evaluation of separated diastereomers revealed unexpected differences between the isomers.
MeSH terms
-
Anti-HIV Agents / chemistry
-
Anti-HIV Agents / pharmacology*
-
Binding Sites
-
Cell Line
-
Chemistry, Pharmaceutical / methods
-
Dideoxynucleotides
-
Drug Design
-
Esterases / chemistry
-
HIV / metabolism
-
HIV Infections / drug therapy
-
Humans
-
Hydrolysis
-
Models, Chemical
-
Mutation
-
Nucleotides / chemistry*
-
Prodrugs / chemical synthesis*
-
Prodrugs / chemistry*
-
Protein Isoforms
-
Stavudine / analogs & derivatives*
-
Stavudine / chemical synthesis
-
Stavudine / chemistry
-
Stavudine / pharmacology
-
Thymine Nucleotides
Substances
-
Anti-HIV Agents
-
Cyclosaligenyl-2',3'-didehydro-2',3'-dideoxythymidine monophosphate
-
Dideoxynucleotides
-
Nucleotides
-
Prodrugs
-
Protein Isoforms
-
Thymine Nucleotides
-
Stavudine
-
Esterases